↓ Skip to main content

Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa

Overview of attention for article published in Malaria Journal, January 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
9 news outlets
policy
1 policy source
twitter
6 X users

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
148 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
Published in
Malaria Journal, January 2016
DOI 10.1186/s12936-015-1075-7
Pubmed ID
Authors

Hannah C. Slater, Jamie T. Griffin, Azra C. Ghani, Lucy C. Okell

Abstract

Artemisinin and partner drug resistant malaria parasites have emerged in Southeast Asia. If resistance were to emerge in Africa it could have a devastating impact on malaria-related morbidity and mortality. This study estimates the potential impact of artemisinin and partner drug resistance on disease burden in Africa if it were to emerge. Using data from Asia and Africa, five possible artemisinin and partner drug resistance scenarios are characterized. An individual-based malaria transmission model is used to estimate the impact of each resistance scenario on clinical incidence and parasite prevalence across Africa. Artemisinin resistance is characterized by slow parasite clearance and partner drug resistance is associated with late clinical failure or late parasitological failure. Scenarios with high levels of recrudescent infections resulted in far greater increases in clinical incidence compared to scenarios with high levels of slow parasite clearance. Across Africa, it is estimated that artemisinin and partner drug resistance at levels similar to those observed in Oddar Meanchey province in Cambodia could result in an additional 78 million cases over a 5 year period, a 7 % increase in cases compared to a scenario with no resistance. A scenario with high levels of slow clearance but no recrudescence resulted in an additional 10 million additional cases over the same period. Artemisinin resistance is potentially a more pressing concern than partner drug resistance due to the lack of viable alternatives. However, it is predicted that a failing partner drug will result in greater increases in malaria cases and morbidity than would be observed from artemisinin resistance only.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Netherlands 1 <1%
Vietnam 1 <1%
Unknown 145 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 24%
Student > Ph. D. Student 26 18%
Researcher 19 13%
Student > Bachelor 17 11%
Other 6 4%
Other 18 12%
Unknown 27 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 30 20%
Medicine and Dentistry 26 18%
Biochemistry, Genetics and Molecular Biology 16 11%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Chemistry 7 5%
Other 28 19%
Unknown 33 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2023.
All research outputs
#704,280
of 24,833,004 outputs
Outputs from Malaria Journal
#77
of 5,816 outputs
Outputs of similar age
#12,589
of 404,938 outputs
Outputs of similar age from Malaria Journal
#2
of 167 outputs
Altmetric has tracked 24,833,004 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,816 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.